Skip to main content
Clinical Trials/CTRI/2023/10/058846
CTRI/2023/10/058846CompletedUnknown

Consumer survey to evaluate the effects of Mintop Serum in management of hair fall.

Dr. Reddys Laboratories Ltd.,1 site in 1 country165 target enrollmentStarted: October 26, 2023Last updated:

Trial Snapshot

Phase
Unknown
Status
Completed
Sponsor
Enrollment
165
Locations
1
Primary Endpoint
Evaluation of Reduction in hair fall by Consumer questionnaire, hair pull test and 1 min comb test.

Study Overview

Brief Summary

Mintop serum is a test product and claims to help hair growth. In this consumer survey the

effectiveness of Mintop serum on various hair parameters will be evaluated by using a

consumer feedback questionnaire.

Results: The study was completed with 161 complete cases and no adverse events were reported during the study.

Study Design

Study Type
Interventional
Allocation
Not Applicable
Masking
Not Applicable

Eligibility Criteria

Ages
18.00 Year(s) to 55.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • Women between 18 and 55 years (inclusive) of age willing to participate voluntarily.
  • Participants having self-declared hair fall (confirmed by hair pull test).
  • Participants who are able to understand written and/or verbal instructions and are ready to comply with all survey requirements with a willingness to participate and ready to give written informed consent voluntarily.
  • Agreeing to use only test product (Mintop serum) provided by Sponsor for hair fall management.

Exclusion Criteria

  • Allergic to any cosmetic product.
  • Pregnant women or lactating mothers.
  • Any clinical hair condition for which treatment is being taken.
  • History of thyroid, anaemia or hormonal problems
  • Participants who had Covid infection during the past 6 months.
  • Participants who had fever and prolonged illness recently.

Outcomes

Primary Outcomes

Evaluation of Reduction in hair fall by Consumer questionnaire, hair pull test and 1 min comb test.

Time Frame: Baseline, 1 month, 3 month

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Dr. Reddys Laboratories Ltd.,
Sponsor Class
Pharmaceutical industry-Global

Study Sites (1)

Loading locations...

Similar Trials